FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Janssen Pharmaceuticals Ortho-Cept Recall

Ortho-Cept (0

Janssen Pharmaceuticals, Inc. · Titusville, NJ

Risk level
Class II
Reported by FDA
May 20, 2015
Recall ID
D-1063-2015
Check your lot numberHow we source this data

Summary

Janssen Pharmaceuticals recalled Ortho-Cept starting Apr 29, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1063-2015 on May 20, 2015. Reason: Subpotent Drug. Status: Terminated.

Why it was recalled

Subpotent Drug

Product description

Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only, Jointly Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674 and NV Organon, Oss, The Netherlands, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560, New Jersey, NDC 50458-0196-15.

Lot numbers, UPCs & expiration codes

Lot # 13CM724, Exp.09/15 (US) Lot # (L) 13DM732, Exp. 09/15 (Canada)

Where it was sold

Nationwide and Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1063-2015
Classification
Class II
Status
Terminated
Recall initiated
Apr 29, 2015
FDA report date
May 20, 2015
Quantity
16,861 cartons/6 blister units (28 tablets) each
Recall type
Voluntary: Firm initiated
Recalling firm
Janssen Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1063-2015, exactly as published.

Show all FDA fields
City
Titusville
State
NJ
Status
Terminated
Country
United States
Event ID
71064
Address
1125 Trenton-Harbourton Rd
Code information
Lot # 13CM724, Exp.09/15 (US) Lot # (L) 13DM732, Exp. 09/15 (Canada)
Postal code
08560-1503
Report date
May 20, 2015
Product type
Drugs
Recall number
D-1063-2015
Classification
Class II
Recalling firm
Janssen Pharmaceuticals, Inc.
Product quantity
16,861 cartons/6 blister units (28 tablets) each
Termination date
Jul 13, 2018
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ortho-Cept (0.15 mg desogestrel and 0.03 mg ethinyl estradiol) tablets, 28- count blister (21 active tablets and 7 placebo tablets)/ 6 blister packs per carton. Rx only, Jointly Manufactured by: Janssen Ortho, LLC, Manati, Puerto Rico 00674 and NV Organon, Oss, The Netherlands, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, New Jersey 08560, New Jersey, NDC 50458-0196-15.
Distribution pattern
Nationwide and Canada
Recall initiation date
Apr 29, 2015
Initial firm notification
E-Mail
Center classification date
May 11, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1063-2015, published May 20, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls